Hedge Fund - Baker Bros. Advisors
Ascendis Pharma A/S (ASND)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2023 - Q1 (2023-03-31) | $0 | 0% | 0 | $114.40 |
| 2 | 2022 - Q4 (2022-12-31) | $605,136,441 | 3.63% | 4,954,855 | $116.10 |
| 3 | 2022 - Q3 (2022-09-30) | $501,085,000 | 3.28% | 4,852,655 | $94.81 |
| 4 | 2022 - Q2 (2022-06-30) | $451,103,000 | 2.55% | 4,852,655 | $94.25 |
| 5 | 2022 - Q1 (2022-03-31) | $533,003,000 | 3.06% | 4,541,604 | $115.81 |
| 6 | 2021 - Q4 (2021-12-31) | $610,982,000 | 2.97% | 4,541,604 | $148.75 |
| 7 | 2021 - Q3 (2021-09-30) | $723,886,000 | 3.17% | 4,541,604 | $136.86 |
| 8 | 2021 - Q2 (2021-06-30) | $465,723,000 | 2.04% | 3,540,270 | $133.25 |
| 9 | 2021 - Q1 (2021-03-31) | $456,270,000 | 1.97% | 3,540,270 | $151.98 |
| 10 | 2020 - Q4 (2020-12-31) | $590,446,000 | 2.22% | 3,540,270 | $165.37 |
| 11 | 2020 - Q3 (2020-09-30) | $546,334,000 | 2.18% | 3,540,270 | $143.74 |
| 12 | 2020 - Q2 (2020-06-30) | $501,421,000 | 2.21% | 3,390,270 | $137.30 |
| 13 | 2020 - Q1 (2020-03-31) | $381,778,000 | 2.35% | 3,390,270 | $129.93 |
| 14 | 2019 - Q4 (2019-12-31) | $471,654,000 | 2.5% | 3,390,270 | $111.10 |
| 15 | 2019 - Q3 (2019-09-30) | $326,551,000 | 2.22% | 3,390,270 | $111.55 |
| 16 | 2019 - Q2 (2019-06-30) | $390,390,000 | 2.65% | 3,390,270 | $119.66 |
| 17 | 2019 - Q1 (2019-03-31) | $399,035,000 | 2.55% | 3,390,270 | $87.57 |
| 18 | 2018 - Q4 (2018-12-31) | $177,760,000 | 1.45% | 2,837,352 | $62.83 |
| 19 | 2018 - Q3 (2018-09-30) | $201,055,000 | 1.32% | 2,837,352 | $68.83 |
| 20 | 2018 - Q2 (2018-06-30) | $188,741,000 | 1.41% | 2,837,352 | $65.76 |
| 21 | 2018 - Q1 (2018-03-31) | $185,563,000 | 1.57% | 2,837,352 | $56.20 |
| 22 | 2017 - Q4 (2017-12-31) | $104,910,000 | 0.9% | 2,618,818 | $36.36 |
| 23 | 2017 - Q3 (2017-09-30) | $85,145,000 | 0.69% | 2,348,840 | $28.70 |
| 24 | 2017 - Q2 (2017-06-30) | $48,621,000 | 0.42% | 1,751,463 | $26.42 |
| 25 | 2017 - Q1 (2017-03-31) | $37,841,000 | 0.3% | 1,351,463 | $25.27 |
| 26 | 2016 - Q4 (2016-12-31) | $20,711,000 | 0.2% | 1,023,266 | $19.97 |
| 27 | 2016 - Q3 (2016-09-30) | $14,985,000 | 0.13% | 745,521 | $16.51 |
| 28 | 2016 - Q2 (2016-06-30) | $9,893,000 | 0.1% | 745,521 | $15.41 |
| 29 | 2016 - Q1 (2016-03-31) | $9,377,000 | 0.09% | 505,521 | $17.76 |
| 30 | 2015 - Q4 (2015-12-31) | $9,261,000 | 0.07% | 505,521 | $17.53 |
| 31 | 2015 - Q3 (2015-09-30) | $7,709,000 | 0.07% | 435,540 | $19.47 |
| 32 | 2015 - Q2 (2015-06-30) | $1,768,000 | 0.01% | 100,000 | $17.50 |
| 33 | 2015 - Q1 (2015-03-31) | $1,735,000 | 0.01% | 100,000 | $18.18 |
The displayed share prices are average quarterly stock market prices.